Most Read Articles
6 days ago
Percutaneous coronary intervention (PCI) is a safe procedure to perform on obese and morbidly obese patients, a recent study has shown.
Roshini Claire Anthony, 11 Jun 2018

Patients who received a combination of ticagrelor plus aspirin within 24 hours of undergoing coronary artery bypass grafting (CABG) had significantly improved saphenous vein graft patency rates 1 year post-procedure compared with those who only received aspirin, according to findings of the DACAB* trial.

3 days ago
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
Pearl Toh, 3 days ago
Drinking more water did not significantly slow down the decline in kidney function of patients with stage 3 chronic kidney disease (CKD) at 1 year compared with patients who maintained their daily water intake, the CKD WIT* randomized study suggests.

Penile prostheses safe, well-accepted

21 May 2018
Sexual health in men – supplements vs medication

In men with severe erectile dysfunction (ED), primary (PPP) or secondary (SPP) penile prosthesis implantation is safe and well-accepted by the patients and their partners, a recent study has found.

Over a median follow-up period of 24.5 months, the median score on the Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS) was 86.4 points, indicating high overall satisfaction. Scores were comparable between patients who received PPP and SPP (87.5 vs 56.8 points; p=0.267).

The partners’ median EDITS scores also suggested high overall satisfaction with the intervention (66.7 points). There was no significant difference in the scores of partners in the PPP and SPP group (66.7 vs 33.3 points; p=0.24).

At a median follow-up of 26 months, 88.4 percent of the prostheses were still functional. This proportion was significantly higher in the PPP vs SPP group (94.4 percent vs 57.1 percent; p=0.024). The overall mean prosthesis survival was 63 months and was comparable between the two groups (67.0 months in the PPP group vs 55.5 months in the SPP group; p=0.169).

The findings of the present study support the use of penile prosthesis as an effective option for severe ED patients who do not respond to less invasive treatments, researchers said.

Researchers performed a retrospective study of 51 patients with severe ED (median age 61 years), of whom 41 received PPP and 10 received SPP. All SPP implants were placed following failure of PPP. The most common causes of ED were radical prostatectomy (27.5 percent) and diabetes (21.6 percent).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Percutaneous coronary intervention (PCI) is a safe procedure to perform on obese and morbidly obese patients, a recent study has shown.
Roshini Claire Anthony, 11 Jun 2018

Patients who received a combination of ticagrelor plus aspirin within 24 hours of undergoing coronary artery bypass grafting (CABG) had significantly improved saphenous vein graft patency rates 1 year post-procedure compared with those who only received aspirin, according to findings of the DACAB* trial.

3 days ago
Higher activity of plasma xanthine oxidase appears to be linked to insulin resistance and liver dysfunction among type 2 diabetes mellitus (T2DM) patients with metabolic syndrome (MetS), according to a recent Japan study.
Pearl Toh, 3 days ago
Drinking more water did not significantly slow down the decline in kidney function of patients with stage 3 chronic kidney disease (CKD) at 1 year compared with patients who maintained their daily water intake, the CKD WIT* randomized study suggests.